TransMedics GroupMEX:TMDX 48 Market Cap is MXN41,693 Mil as of Jul. 06, 2026. GuruFocus rates MEX:TMDX with a GF Score™ of 48/100 and a GF Value™ of MXN2,975.84 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 868 Medical Devices & Instruments companies, TransMedics Group ranks better than 89.17% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TransMedics Group's share price for the quarter that ended in Mar. 2026 was MXN1800. TransMedics Group's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 35 Mil. Therefore, TransMedics Group's market cap for the quarter that ended in Mar. 2026 was MXN62,183 Mil.
TransMedics Group's quarterly market cap
increased
from Sep. 2025 (MXN70,233 Mil) to Dec. 2025 (MXN79,485 Mil) but then
declined
from Dec. 2025 (MXN79,485 Mil) to Mar. 2026 (MXN62,183 Mil).
TransMedics Group's annual market cap
stayed the same
from Dec. 2023 (MXN0 Mil) to Dec. 2024 (MXN0 Mil) but then
increased
from Dec. 2024 (MXN0 Mil) to Dec. 2025 (MXN79,485 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TransMedics Group's Enterprise Value for Today is MXN48,730 Mil.
TransMedics Group (MEX:TMDX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
TransMedics Group Market Cap Related Terms
TransMedics Group Market Cap Historical Data
* Premium members only.
The historical data trend for TransMedics Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:TMDX vs AXGN, BFLY, ESTA: Market Cap Comparison
For the Medical Devices subindustry, TransMedics Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TransMedics Group Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's Market Cap distribution charts can be found below:
* The bar in red indicates where TransMedics Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
TransMedics Group's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TransMedics Group (MEX:TMDX) has a Market Cap of MXN41,693 Mil as of Jul. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TransMedics Group and its competitors. According to the industry distribution chart, TransMedics Group ranks #94 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 10.8%.
Is TransMedics Group's Market Cap too high?
TransMedics Group's current Market Cap is MXN41,693 Mil. Based on the distribution chart, TransMedics Group ranks #94 out of 868 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, TransMedics Group has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TransMedics Group's Market Cap compare to AXGN and BFLY?
According to the Medical Devices & Instruments industry distribution chart, TransMedics Group ranks #94 out of 868 companies for Market Cap. This places TransMedics Group in the top 11% of its industry — outperforming the majority of peers. The industry median Market Cap is 120.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.17, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TransMedics Group and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TransMedics Group's current Market Cap is MXN41,693 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransMedics Group stock overvalued right now?
Based on GuruFocus' analysis, TransMedics Group (MEX:TMDX) is currently considered Possible Value Trap. The stock's GF Value™ is MXN2,975.84, compared to a current price of MXN1,194.00 — trading 59.9% below its estimated fair value. The current Market Cap is MXN41,693 Mil. TransMedics Group's overall GF Score™ is 48/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For TransMedics Group (MEX:TMDX), the current Market Cap is MXN41,693 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TransMedics Group (MEX:TMDX) Overvalued in 2026?
Based on GuruFocus' analysis, TransMedics Group stock appears to be undervalued.
The current stock price of MXN1,194.00 is trading 59.9% below its estimated GF Value™ of MXN2,975.84.
GuruFocus considers TransMedics Group to be Possible Value Trap.
Key valuation signals for MEX:TMDX:
Market Cap: MXN41,693 Mil
GF Value™: MXN2,975.84 vs. price of MXN1,194.00 (59.9% below fair value)
No single metric tells the full story. See the MEX:TMDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
48GF Score
Get the complete analysis for MEX:TMDX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TMDX has been successfully added to your 
